Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 1/2005

01-02-2005 | Letter

Hyperimmunoglobulinemia D syndrome in an Arab child

Author: Mohammed Hammoudeh

Published in: Clinical Rheumatology | Issue 1/2005

Login to get access

Abstract

Hyperimmunoglobulinemia D syndrome (HIDS) is newly recognized and resembles familial Mediterranean fever (FMF). It is inherited as an autosomal recessive trait. Mutation of the gene coding for mevalonate kinase is responsible for the disease. The gene is located at chromosome 12q24. The patients initially described were of Dutch ancestry. Other cases from Turkey and Armenia were reported. The case we present is the first from Arab countries to be registered in the International HIDS Registry and to our knowledge the first to be reported.
Literature
1.
van der Meer JWM, Vossen JM, Radl J, van Nieuwkoop JA, Meyer CJ, Lobatto S, van Furth R (1984) Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet 1:1087–1090
2.
Drenth JPH, Haagsma CJ, van der Meer JWM, International Hyper-IgD Study Group (1994) Hyperimmunoglobulinemia D and periodic fever syndrome: the clinical spectrum in a series of 50 patients. Medicine 73:133–144PubMedCrossRef
3.
Tsimaratos M, Kone-Paul I, Divry P, Philip N, Chabrol B (2001) Mevalonic aciduria and hyper-IgD syndrome: two sides of the same coin. J Inhert Metab Dis 24:413–414CrossRef
4.
5.
Drenth JP, Boom BW, Toonstra J, van der Meer JW (1994) Cutaneous manifestations and histologic findings in the hyperimmunoglobulinemia D syndrome. International Hyper-IgD Study Group. Arch Dermatol 130:59–65PubMedCrossRef
6.
Drenth JP, Powell RJ (2000) Hyper IgD syndrome and familial Hibernian fever are true periodic fever syndromes. J Pediatr 137:438–439PubMedCrossRef
7.
8.
Drenth JP, van deuren M, van der Ven J, Schalkwijk CG, van der Meer JW (1995) Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood J 85:3586–3593
9.
Simon A, Cuisset L, Vincent F, van der Velde-Visser SD, Delpech M, van der Meer JMW, Drenth JPH for the International HIDS Study Group (2001) Molecular analysis of the mevalonate kinase gene in a cohort of patients with the hyper-IgD and periodic fever syndrome: its application as a diagnostic tool. 135:338–343
10.
Drenth JP, Vonk AG, Simon A, Powell R, van der Meer JW (2001) Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper IgD and periodic fever syndrome: a randomized double blind placebo controlled trial. J Pharmacol Exp Ther 298:1221–1226PubMed
11.
Picco P, Gattorno M, Di Rocco M, Buoncompagni A (2001) Non-steroidal anti-inflammatory drugs in the treatment of hyper IgD syndrome. Ann Rheum Dis 60:904PubMedCentralPubMed
12.
Medleg-Hisham M, Petit I, Adib S, et al. (2001) Familial Mediterranean fever association with elevated IgD plasma level with specific MEFM mutation. Eur J Hum Genet 9:849–854CrossRef
Metadata
Title
Hyperimmunoglobulinemia D syndrome in an Arab child
Author
Mohammed Hammoudeh
Publication date
01-02-2005
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2005
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-004-0953-0

Other articles of this Issue 1/2005

Clinical Rheumatology 1/2005 Go to the issue

Original Article

Comparison of early and late pleuropulmonary findings of ankylosing spondylitis by high-resolution computed tomography and effects on patients’ daily life

Case Report

p-ANCA-associated periaortitis with histological proof of Wegener’s granulomatosis: case report

Original Article

Polymorphism of interleukin-10 promoter and tumor necrosis factor receptor II in Vietnamese patients with systemic lupus erythematosus

Case Report

Kikuchi-Fujimoto’s disease associated with systemic lupus erythematosus: case report and review of the literature

Original Article

Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS

Case Report

Relapsing arterial aneurysms in juvenile Behçet’s disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits